NIFTY Pharma remains resilient amid mixed market sentiment

Pharma and healthcare stocks stay in focus as investors track earnings, USFDA approvals, hospital growth, and global market pressures

SK Capital sells Noramco assets to Siegfried

Keeps Halo Pharma to drive independent growth

ARTEMIS study shows significant gains in adolescent mental health across urban slums in India

The George Institute India’s large-scale community-based model demonstrates reduced depression, self-harm, and suicide risk among adolescents in Delhi and Vijayawada

Livasa Hospitals appoints Kamal Kant Gambhir as Chief Financial Officer

Gambhir brings over 35 years of rich experience in strategic finance, governance, business transformation, and leadership

Our hybrid model combines global manufacturing with local clinical scale: Kavinder Beniwal, Chief Operational Officer, Motorica India

With the convergence of AI, robotics, and neuroscience, Motorica is advancing toward more intuitive, intent-driven prosthetic systems

Syngene reports FY26 revenue of Rs 3,739 Cr, up 3%; Q4 revenue at Rs 1,037 Cr

Steady growth led by biologics and CRDMO business, EBITDA margin at 25% with continued investments in ADCs, peptides, and digital capabilities

Zealand Pharma and Roche charge into Phase 3 with obesity drug bet

The Danish biotech company confirmed the global study will begin in the second half of 2026

Ferrotec launches fast & flexible DNA/RNA isolation kit aimed at streamlining lab workflows

AbbVie seeks FDA nod for RINVOQ use in severe alopecia areata

After Phase 3 results show major hair regrowth gains

Biosimilars gain momentum as US market sees 92 approvals: Samsung Bioepis report

Q2 2026 analysis shows expanding approvals, stronger uptake, and a shift toward evidence-driven biosimilar evaluation